Actos & Bladder Cancer Lawsuit Information

Recently a 10 year study revealed that diabetes patients who took Actos for an extended period of time may be at risk for developing Bladder Cancer.

In September 2010, the FDA announced that makers of Actos, Takeda Pharmaceuticals, provided data after five years of the study that suggests there may be a risk of bladder cancer from Actos.

According to the study, if a patient has taken Actos for more than 24 months, they may be at an increased risk of Bladder Cancer from Actos side effects. It appears that this information about the potential risk of Actos cancer problems has been known to Takeda, manufacturer of Actos, for a period of time, warnings were provided to consumers and the medical community.

Some experts believe that recall should be issued or that new warnings about the risk of bladder cancer from Actos should be added to the medication. Actos was recently withdrawn from the market in France and Germany due to its association with bladder tumors. Due to these and other serious side effects, the FDA recently announced a link between Actos and an increased incidence of bladder cancer.

Actos Bladder Cancer lawyer Peterson& Associates, P.C. is currently accepting individuals who have taken Actos and have symptoms of or have been diagnosed with Bladder cancer.